Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Liu

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
JCO Precision Oncology|December 1, 2022
Use of Erdafitinib in <i>FGFR3</i>-Mutated Recurrent Respiratory PapillomatosisVincent Yeung, Paul Sackstein, Nazaneen N Grant, et al.
Lung Cancer (Amsterdam, Netherlands)|October 16, 2021
Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancersMartin Gutierrez, Robin Guo, Giuseppe Giaccone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2010
Expression of receptors for luteinizing hormone-releasing hormone (LH-RH) in prostate cancers following therapy with LH-RH agonistsStephen V Liu, Andrew V Schally, Debra Hawes, et al.
Anticancer Research|March 31, 2018
Racial Disparities in the Molecular Landscape of CancerElisabeth I Heath, Filipa Lynce, Joanne Xiu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 23, 2021
Index Admission and Thirty-Day Readmission Outcomes of Patients With Cancer Presenting With STEMIMohammed Osman, Mina M Benjamin, Sudarshan Balla, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2023
High levels of expression of Trop-2 in thymic epithelial tumorsVincent Yeung, Jacob Zaemes, Justin Yeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group TrialMaria E Cabanillas, Jonas A de Souza, Susan Geyer, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
JTO Clinical and Research Reports|December 6, 2022
Remarkable Intracranial Response to Sotorasib in a Patient With <i>KRAS</i> <sup>G12C</sup>-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case ReportJustin Yeh, Jennifer A Marks, Ali H Alzeer, et al.
Clinical Lung Cancer|February 21, 2021
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at ProgressionMaya N White, Zofia Piotrowska, Kevin Stirling, et al.
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
JCO Precision Oncology|December 1, 2022
Use of Erdafitinib in <i>FGFR3</i>-Mutated Recurrent Respiratory PapillomatosisVincent Yeung, Paul Sackstein, Nazaneen N Grant, et al.
Lung Cancer (Amsterdam, Netherlands)|October 16, 2021
Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancersMartin Gutierrez, Robin Guo, Giuseppe Giaccone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2010
Expression of receptors for luteinizing hormone-releasing hormone (LH-RH) in prostate cancers following therapy with LH-RH agonistsStephen V Liu, Andrew V Schally, Debra Hawes, et al.
Anticancer Research|March 31, 2018
Racial Disparities in the Molecular Landscape of CancerElisabeth I Heath, Filipa Lynce, Joanne Xiu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 23, 2021
Index Admission and Thirty-Day Readmission Outcomes of Patients With Cancer Presenting With STEMIMohammed Osman, Mina M Benjamin, Sudarshan Balla, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2023
High levels of expression of Trop-2 in thymic epithelial tumorsVincent Yeung, Jacob Zaemes, Justin Yeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group TrialMaria E Cabanillas, Jonas A de Souza, Susan Geyer, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
JTO Clinical and Research Reports|December 6, 2022
Remarkable Intracranial Response to Sotorasib in a Patient With <i>KRAS</i> <sup>G12C</sup>-Mutated Lung Adenocarcinoma and Untreated Brain Metastases: A Case ReportJustin Yeh, Jennifer A Marks, Ali H Alzeer, et al.
Clinical Lung Cancer|February 21, 2021
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at ProgressionMaya N White, Zofia Piotrowska, Kevin Stirling, et al.
Pageof 19